|[February 05, 2014]
China's Largest Life Science Partnering Event Returns to Suzhou, China
CARLSBAD, Calif. & SUZHOU, China --(Business Wire)--
The 2014 edition of ChinaBio®
Partnering Forum, China's premier life science partnering event,
will be held May 7-8 at the Kempinski Hotel in Suzhou.
In 2013, the Forum was attended by more than 750 delegates from 405
companies and 22 countries, making it the largest partnering conference
in China. Pharma and biotech companies as well as leading researchers
from China's top universities and institutes consider it a must-attend
event for establishing a presence in China's expansive in-demand
"The event has been extremely successful, and has edged out the
competition making it the only successful life science partnering event
in China," said Greg B. Scott, President and Founder of ChinaBio®
LLC. "There is still huge market potential, and interest in new
drugs and healthcare options is only growing in China. Companies who
want to secure a foothold there will find exponential opportunities."
"China is a burgeoning market and there is a lot of potential for
innovative companies including biotech and pharma, contract research
organizations and investors," said Florian Schoenhammer, Group
Managing Director, EBD Group. "We are looking at the real-time
transformation of China's biotech and life science ecosystem.
Undeniably, international companies are eager to build relationships in
China to meet growing demand."
The event is recognized by life science insiders as the largest and most
productive partnering event for established biotech and early-stage
companies to meet and collaborate with China-based corporate partners,
including venture capitalists and business development executives from
big pharma companies.
"China faces the same burdens of chronic disease as the West, and this
burden represents a huge opportunity in terms of market potential," said Gangfeng
Xu, Divisional VP, Corporate Licensing & Acquisitions, Abbott
Laboratories. "We are actively seeking innovative partnerships in China
that will address current and future health concerns."
Innovative companies, organizations or researchers interested in
partnering their technologies or products, initiating strategic
alliances, or tapping into the financing network are encouraged to apply
to present. Applications
to present are currently in review, and should be submitted before
the February 28, 2014 deadline.
before March 14 and save USD 200 off the regular registration fee.
partneringONE® is EBD Group's sophisticated, web-based
partnering system that enables event delegates to efficiently identify,
meet and get partnerships started with companies across the life science
value chain, from large biotech and pharma companies to financiers and
About ChinaBio ® LLC:
Since its founding in January, 2007, ChinaBio® LLC has
rapidly created a broad platform of capabilities connecting China life
science with the world. ChinaBio has helped global life science
companies identify over 400 licensing and acquisition opportunities in
China and China companies raise over USD 450 million.
Conferences: ChinaBio organizes the premier life science investment
and partnering conferences in China, having attracted over 4,000
Consulting: ChinaBio works with global life science companies and
China entrepreneurs to define and execute a successful global strategy.
Capital: ChinaBio helps companies secure partnerships and acquisitions
and access private and government funding in China.
Publishing: ChinaBio® Today is the most widely read online
and email newsletter on China's life science industry, with over
More information is available at www.chinabiollc.com.
About EBD Group
EBD Group is the leading partnering firm for the global life science
industry. Since 1993, biotech, pharma and medical device companies have
leveraged EBD Group's partnering conferences, technology and services to
identify business opportunities and develop strategic relationships
essential to their success.
EBD Group's conferences are run with the support of leading corporations
and international trade associations and include:
BIO-Europe Spring®, Europe's largest life science partnering
conferences, supported by the Biotechnology Industry Organization (BIO)
America™, the fastest growing partnering event in North America
Showcase™, a unique forum in San Francisco for presenting to
investors and business development executives, co-produced with
Demy-Colton Life Science Advisors
Europe, the investor conference co-organized with BioCentury
Publications and BIO
Partnering Forum, the first dedicated biotech/pharma partnering
conference in China, co-produced with ChinaBio® LLC
EBD Group's partnering event for the innovative medical technology
The Global Impact Forum, a unique and innovative partnering conference
in impact investing and venture philanthropy.
EBD Group's sophisticated web-based partnering service, partneringONE®,
is used as the partnering engine at numerous third-party events around
the world, and partnering360® is the open
online community of life science dealmakers that enhances partnering
experiences throughout the year.
EBD Group is an Informa (News - Alert) company. Informa is the largest publicly-owned
organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140205006608/en/
[ Back To TMCnet.com's Homepage ]